Your account is not claimed yet. You can sign up with ORCID to claim your account.

Núria Profitós-Pelejà (Nuria Profitos-Peleja, Núria Profitós Pelejà)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Venues

Cells

Cancers

Clinical cancer research : an official journal of the American Association for Cancer Research

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Juliana Carvalho Santos, Núria Profitós-Pelejà, Salvador Sánchez-Vinces, Gael Roué
RHOA Therapeutic Targeting in Hematological Cancers. Cells 12 (3) (2023)
Juliana Carvalho Santos, Núria Profitós-Pelejà, Salvador Sánchez-Vinces, Gael Roué
RHOA Therapeutic Targeting in Hematological Cancers. Cells 12 (3) (2023)
Juliana Carvalho Santos, Núria Profitós-Pelejà, Salvador Sánchez-Vinces, Gael Roué
RHOA Therapeutic Targeting in Hematological Cancers. Cells 12 (3) (2023)
Juliana Carvalho Santos, Núria Profitós-Pelejà, Salvador Sánchez-Vinces, Gael Roué
RHOA Therapeutic Targeting in Hematological Cancers. Cells 12 (3) (2023)
Grégoire Quinet, Wendy Xolalpa, Diana Reyes-Garau, Núria Profitós-Pelejà, Mikel Azkargorta, Laurie Ceccato, Maria Gonzalez-Santamarta, Maria Marsal, Jordi Andilla, Fabienne Aillet, Francesc Bosch, Felix Elortza, Pablo Loza-Alvarez, Brigitte Sola, Olivier Coux, Rune Matthiesen, Gael Roué, Manuel S Rodriguez
Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma. Cancers 14 (4) (2022)
Núria Profitós-Pelejà, Juliana Carvalho Santos, Ana Marin-Niebla, Gael Roué, Marcelo Lima Ribeiro
Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas. Cancers 14 (4) (2022)
Juliana Carvalho Santos, Núria Profitós-Pelejà, Marcelo Lima Ribeiro, Gael Roué
Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma. Cancers 14 (22) (2022)
Marcelo Lima Ribeiro, Diana Reyes-Garau, Meritxell Vinyoles, Núria Profitós-Pelejà, Juliana Carvalho Santos, Marc Armengol, Miranda Fernandez-Serrano, Alícia Sedó Mor, Joan J Bech-Serra, Pedro Blecua, Eva Musulen, Carolina de la Torre, Hari Miskin, Manel Esteller, Francesc Bosch, Pablo Menéndez, Emmanuel Normant, Gael Roué
Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Emma Kennedy, Eve Coulter, Emma Halliwell, Núria Profitós-Pelejà, Elisabeth Walsby, Barnaby Clark, Elizabeth H Phillips, Thomas A Burley, Christopher Iain Jones, Stephen Devereux, Christopher D Fegan, Rosalynd Johnston, Timothy J T Chevassut, Ralph Schulz, Martina Seiffert, Angelo Agathanggelou, Ceri E Oldreive, Nicholas Davies, Tatjana Stankovic, Triantafillos Liloglou, Christopher J Pepper, Andrea G S Buggins
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target. Blood 137 (22) (2021)

Núria Profitós-Pelejà.css-eqlu8i{font-size:small;padding-left:4px;} (Nuria Profitos-Peleja, Núria Profitós Pelejà)

Publication Activity (10 Years)

Top Topics

Top Venues

Núria Profitós-Pelejà (Nuria Profitos-Peleja, Núria Profitós Pelejà)